Summary
Preventive treatment of Type 1 (insulin-dependent) diabetes presupposes early and accurate diagnosis of prediabetic states. The low acute insulin response to intravenous glucose has been proposed as a marker of both pre-Type 1 and pre-Type 2 (non-insulin-dependent) diabetes. In order to test the reliability of this marker for clinical detection of Type 1 diabetes we looked for this anomaly in 150 first degree relatives of Type 1 diabetic patients, 31 relatives of Type 2 diabetic patients and 39 young non-obese diabetic patients with mild or transient hyperglycaemia. The low acute insulin response was defined by a peak insulin value (sum of plasma insulin at 2 and 5 min after glucose load, 0.3 g/kg body weight) below 50 μU/ml. It was observed in 12% of the relatives of Type 1 diabetic patients (2 of them became diabetic) and in 13% of the relatives of Type 2 diabetic patients. Reproducibility of the peak insulin value in 2 subsequent tests (r=0.749) was inadequate to interpret small variations in one individual. In the population of 39 diabetic patients, 10 subsequently developed typical Type 1 diabetes, 9 were low insulin responders. In the 29 patients who are still non-insulin-dependent 3 years later, the anomaly was found in the 3 islet cell antibody-positive subjects and 11 out of 26 patients with no detectable antibodies. In conclusion, low acute insulin response to glucose is a sensitive but non-specific marker of early stages of Type 1 diabetes as this anomaly is shared by both Type 2 and Type 1 diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Eisenbarth GS (1986) Type I Diabetes Mellitus, A chronic autoimmune disease. N Engl J Med 314: 1360–1368
Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS (1984) Pré-type I diabetes: linear loss of beta cell response to intravenous glucose. Diabetes 33: 713–720
Srikanta S, Ganda OP, Rabizadeh A, Soelner JS, Eisenbarth GS (1985) First degree relatives of patients with type I diabetes mellitus. Islet cell antibodies and abnormal insulin secretion. N Engl J Med 313: 461–464
Ginsberg-Fellner F, Witt ME, Franklin BM, Yagihashi S, Togushi Y, Dobersen MS, Rubinstein P, Notkins AL (1985) Triad of markers for identifying children at risk of developing insulin-dependent diabetes mellitus. JAMA 254: 1469–1472
Cerasi E, Luft R (1967) The plasma insulin response to gluocse infusion in health subjects and in diabetes mellitus. Acta Endocrinol (Kbh) 55: 278–334
Varsano Aharon N, Echemendia E, Yalow RS, Berson SA (1970) Early insulin response to glucose and to tolbutamide in maturity onset diabetes. Metabolism 19: 401–417
Vague Ph, Ramahandridona G, Gerolami A (1974) Insulin response to glucose and to tolbutamide in essential versus “pancreatic” mild glucose intolerance. Diabetes 23: 896–901
Fujita Y, Herron AL, Selizer HS (1975) Confirmation of impaired early insulin response to glycaemic stimulus in non obese mild diabetes. Diabetes 24: 17–27
Ratzmann KP, Schulte B, Heinke P, Michaelis D (1981) Quantitative and qualitative changes in the early insulin response to glucose in subjects with impaired carbohydrate tolerance. Diabetes Care 4: 85–91
Fajans SS, Cloutier MC, Crowther RL (1979) Heterogeneity of idiopathic diabetes mellitus in man. In: Vague J, Vague Ph (eds) Diabetes and Obesity. Excerpta Medica, Amsterdam, pp 73–82
Vialettes B, Di Campo-Rougerie C, Lassmann V, Vague Ph (1983) Comparaison de divers types d'anticorps anti-ilots dans le diabète en fonction de la cause et de la durée d'évolution. Presse Médicale 12: 2303–2306
Gorsuch AN, Spencer KH, Lister J, Mc Nally JM, Dean BM, Bottazzo GF, Cudworth AG (1981) Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet II: 1363–1365
Orchard TJ, Rosembloom AL (1985) The development of insulin-dependent diabetes mellitus among relatives. Diabetes Care 8 [Suppl]: 45–50
Smith CP, Tarn AC, Thomas JM, Ovekamp D, Corakci A, Savage MO, Gale EAM (1988) Between and within subject variations of the first phase insulin response to intravenous glucose. Diabetologia 31: 123–125
Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte D (1976) Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance test. J Clin Endocrinol Metab 42: 222–229
Cerasi E, Luft R (1967) What is inherited, what is added? Hypothesis for pathogenesis of diabetes mellitus. Diabetes 16: 615
Vague Ph, Ramahandridona G, Vague J (1975) Proportion de faibles secréteurs d'insuline parmi les descendants des diabétiques de l'age mur. Diabete Metab 1: 45–50
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vialettes, B., Mattei-Zevaco, C., Badier, C. et al. Low acute insulin response to intravenous glucose. A sensitive but non-specific marker of early stages of Type 1 (insulin-dependent) diabetes. Diabetologia 31, 592–596 (1988). https://doi.org/10.1007/BF00264765
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00264765